(PharmaNewsWire.Com, April 12, 2017 ) According to the report The Nuclear Imaging Market, published by Market Data Forecast, the global market is projected to reach USD 15.34 billion by 2021, at a CAGR of 8.87% from 2016 to 2021.
Nuclear imaging is generally used for cardiovascular and oncology applications. This technology allows doctors to formulate the appropriate alignment of radiation beams for the treatment of disease with sound accuracy. For instance, positron emission tomography (PET) imaging allows doctors to recognize chemical and physiologic variations in targeted tissues. Nuclear imaging market is presenting growth of sound especially in the cardiac segment amid the rising attention that providing the cardiac disease prevention and treatment. Gamma camera imaging is also used in myocardial and cerebral perfusion studies. Positron emission tomography (PET) imaging enables clinicians to recognize physical and chemical changes in tissues. Hybrid positron emission tomography/computed tomography (PET/CT) is the most popularly used in radiosurgery planning as well as enables the fusion of images. For the treatment of disease, this technology allows to plan the best orientation of radiation beams along with good accuracy.
The factors influencing the Global Market for Nuclear Imaging Market, either positively or negatively are presented in the DROC analysis. Some of the things discussed in the section are an increasing utilization of SPECT and PET examination in radiopharmaceuticals, rise in cognizance for prompt diagnosis, increasing frequency of cardiac diseases, and improving healthcare infrastructure in this region.
For granular level understanding the Nuclear Imaging Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segment.
By Diagnostic Technologies: Introduction PET Radioisotopes SPECT Radioisotopes Y-o-Y Growth Analysis, By Diagnostic Technologies Market Attractiveness Analysis, By Diagnostic Technologies Market Share Analysis, By Diagnostic Technologies
By Application: Introduction PET SPECT Y-o-Y Growth Analysis, By Application Market Attractiveness Analysis, By Application Market Share Analysis, By Application
The market has also been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle East. U.S accounted for the largest share in the global Nuclear Imaging market in 2015, as it spends nearly 20% of its GDP on health. However, The Asia-Pacific region is projected to grow at the highest CAGR during the forecast period due to reasons such as growing geriatric populace and surge in the chronic disease population.
North America Nuclear Imaging Market Europe Nuclear Imaging Market Asia-Pacific Nuclear Imaging Market Latin America Nuclear Imaging Market Middle east and Africa Nuclear Imaging Market
The major companies dominating the global Nuclear Imaging market are Mallinckrodt plc. Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (Healthcare Division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.
The Nuclear Imaging Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Nuclear Imaging Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
